Geoff McDonough, Generation Bio
With $110M to add to the bankroll, Generation Bio sets its sights on engineering a revolution in the gene therapy field
Whoever comes out on top of the current race to gain pioneering approvals for new AAV-delivered gene therapies will have to look over their shoulders …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.